Evaluation of growth hormone deficiency in women with unexplained infertility


ORTAÇ M. Ş., HACIOĞLU A., Uludag S. Z., ÖZDAMAR KARACA Z. C., ÜNLÜHİZARCI K., Kelestimur F., ...Daha Fazla

GROWTH HORMONE & IGF RESEARCH, cilt.74, 2024 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 74
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1016/j.ghir.2024.101571
  • Dergi Adı: GROWTH HORMONE & IGF RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
  • Erciyes Üniversitesi Adresli: Evet

Özet

Purpose: Growth hormone (GH) has been recognized to play a regulatory role in female reproduction. It has been reported that infertile GH deficient patients regained fertility after GH replacement. The frequency of GH deficiency is not established in patients diagnosed with unexplained infertility. Here, we aim to present the prevalence of GH deficieny in this patient group. Methods: We included patients diagnosed with unexplained infertility throughout 18 months. Insulin tolerance test (ITT) and glucagon stimulation tests (GST) were performed and insufficient response to both tests was required for the diagnosis of GH deficiency. Results: Twenty-five patients were included in the study, the mean age was 27.4 +/- 4.5 years and the median duration of infertility was 60 months (min:14, max:120). Two patients were GH deficient according to GST and 14 to ITT. Two patients (8%) showed lack of response on both tests and were diagnosed with GH deficiency. Conclusion: The rate of GH deficiency among women with unexplained infertility was 8% in this preliminary study. There is need for further studies with larger patient groups to verify the results.